<item>
  <date>2026-05-27</date>
  <hash>b5b9a1ee7fac146c529d0f0546f0f52e948c10f3</hash>
  <images></images>
  <index>23</index>
  <keywords>
    <name>American Cancer Society</name>
    <index>1</index>
    <slug>/wiki/american%20cancer%20society</slug>
  </keywords>
  <keywords>
    <name>Guardant Health</name>
    <index>13</index>
    <slug>/wiki/guardant%20health</slug>
  </keywords>
  <keywords>
    <name>U.S FDA</name>
    <index>70</index>
    <slug>/wiki/food%20and%20drug%20administration</slug>
  </keywords>
  <keywords>
    <name>blood test</name>
    <index>36</index>
    <slug>/wiki/blood%20test</slug>
  </keywords>
  <keywords>
    <name>colorectal cancer</name>
    <index>115</index>
    <slug>/wiki/colorectal%20cancer</slug>
  </keywords>
  <keywords>
    <name>screenings</name>
    <index>171</index>
    <slug>/wiki/cancer%20screening</slug>
  </keywords>
  <keywords_list>American Cancer Society</keywords_list>
  <keywords_list>Guardant Health</keywords_list>
  <keywords_list>U.S FDA</keywords_list>
  <keywords_list>blood test</keywords_list>
  <keywords_list>colorectal cancer</keywords_list>
  <keywords_list>screenings</keywords_list>
  <keywords_main>American Cancer Society</keywords_main>
  <related>
    <date>2026-01-22</date>
    <hash>95c5a9cd32cd9373cb8cba39b68be4de29f7e022</hash>
    <index>13</index>
    <keywords>colorectal cancer</keywords>
    <score>1</score>
    <slug>/feed/2026/01/22/the-journal-of-the-american-medical-association-reports-that-colorectal-cancer-is-the-leading-cause-of-cancer-death-in-p</slug>
    <text>The Journal of the American Medical Association reports that colorectal cancer is the leading cause of cancer death in people under 50 in the United States. </text>
  </related>
  <related>
    <date>2025-06-18</date>
    <hash>5361d19a5ca75e936f6e925bbf0a51f7a957c389</hash>
    <index>9</index>
    <keywords>U.S FDA</keywords>
    <score>1</score>
    <slug>/feed/2025/06/18/the-us-food-and-drug-administration-approves-gilead-sciences-s-new-lenacapavir-drug-marketed-as-yeztugo-for-the-trea</slug>
    <text>The U.S. Food and Drug Administration approves Gilead Sciences's new lenacapavir drug, marketed as Yeztugo, for the treatment of HIV after successful clinical trials show the drug nearly eliminated the infection spread. </text>
  </related>
  <related>
    <date>2025-05-16</date>
    <hash>a2bf3b66f5ac78526d89fbba6299afd40412feb0</hash>
    <index>8</index>
    <keywords>U.S FDA</keywords>
    <keywords>blood test</keywords>
    <score>2</score>
    <slug>/feed/2025/05/16/the-us-food-and-drug-administration-clears-the-fujirebio-lumipulse-for-distribution-the-first-blood-test-that-can-be</slug>
    <text>The U.S. Food and Drug Administration clears the Fujirebio Lumipulse for distribution, the first blood test that can be used to diagnose Alzheimer's disease in people 55 years or older with memory problems by detecting amyloid plaques. Alzheimer's can currently only be diagnosed using a PET scan. </text>
  </related>
  <related>
    <date>2025-04-15</date>
    <hash>63661837f50d925872ad990e0d169bd3556ffc67</hash>
    <index>11</index>
    <keywords>U.S FDA</keywords>
    <score>1</score>
    <slug>/feed/2025/04/15/the-european-commission-approves-the-use-of-lecanemab-a-monoclonal-antibody-medication-that-targets-amyloid-beta-peptid</slug>
    <text>The European Commission approves the use of Lecanemab, a monoclonal antibody medication that targets amyloid beta peptides, to treat the early stages of Alzheimer's disease via intravenous therapy. This is the first drug to be approved to treat the disease in Europe, and was approved by the Food and Drug Administration in the United States in 2023. </text>
  </related>
  <related>
    <date>2025-01-15</date>
    <hash>6a06ec438cce509580b2ea2007aca0dee2e99dcc</hash>
    <index>12</index>
    <keywords>U.S FDA</keywords>
    <score>1</score>
    <slug>/feed/2025/01/15/the-us-food-and-drug-administration-bans-the-usage-of-red-no-3-artificial-food-coloring-due-to-research-showing-that</slug>
    <text>The U.S. Food and Drug Administration bans the usage of Red No. 3 artificial food coloring, due to research showing that the food coloring is carcinogenic. </text>
  </related>
  <slug>/feed/2026/05/27/the-american-cancer-society-announces-that-the-guardant-health-shield-blood-test-which-was-approved-by-the-us-fda-in-2</slug>
  <sources>
    <name>NBC News</name>
    <day>27</day>
    <hash>7fc0380c0a1fd4e3f83c33810da7095c6d1a51d0</hash>
    <month>5</month>
    <permalink>https://www.nbcnews.com/health/health-news/blood-test-added-colorectal-cancer-screening-options-cancer-group-rcna346902</permalink>
    <year>2026</year>
  </sources>
  <sources>
    <name>Reuters</name>
    <day>27</day>
    <hash>99d91a2d6e951a1a1910a2b7d68943831ab6fbba</hash>
    <month>5</month>
    <permalink>https://www.reuters.com/business/healthcare-pharmaceuticals/blood-test-added-us-colorectal-cancer-screening-options-2026-05-27/</permalink>
    <year>2026</year>
  </sources>
  <text>The American Cancer Society announces that the Guardant Health Shield blood test, which was approved by the U.S FDA in 2024, will be included as an option for colorectal cancer screenings amidst a rise in colon cancer cases in young adults. </text>
</item>
